Journals / MN Oftalmoloji / 2006 / Cilt: 13 - Sayı: 3

Demographic and clinical characteristics of cases with anterior optic neuropathy

Ön optik nöropatili olgularımızda demografik ve klinik özellikler

Pages
211–216
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the literature it was reported that the visual loss was more severe and the visual outcome was better in NION than ION, but in our study, both the visual loss and the visual improvements were better in NION than ION.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the demographic and clinical characteristics in cases with anterior optic neuropathy (AON) followed in our clinic.
📊
Key Findings & Data:Material and Methods: Fifty one eyes of 51 cases who were diagnosed as AON and followed between the years 1994 and 2004 were included in this study.
💡
Conclusion & Impact:In the literature it was reported that the visual loss was more severe and the visual outcome was better in NION than ION, but in our study, both the visual loss and the visual improvements were better in NION than ION.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Optik nöropati · iskemik · Demografi

Abstract

Purpose: To evaluate the demographic and clinical characteristics in cases with anterior optic neuropathy (AON) followed in our clinic. Material and Methods: Fifty one eyes of 51 cases who were diagnosed as AON and followed between the years 1994 and 2004 were included in this study. There were 29 cases with ischemic optic neuropathy (ION) and 22 cases with non-ischemic optic neuropathy (NION) in the study. The demographic and clinical characteristics of cases were determined and all cases were evaluated for systemic diseases by an internist, rheumatologist and neurologist and by a hematologist if required. Results: The mean age of the cases with ION was 62.3±8.5 years. Twenty nine cases with ION consisted of 11 females and 18 males. Systemic disease in cases with ION were: temporal arteritis (2 cases), hypertension (13 cases), diabetes mellitus (6 cases) hypertension and diabetes mellitus (4 cases), chronic obstructive pulmonary disease (2 cases). In 15 cases visual acuities were less than counting fingers at 1 m, in 7 cases counting fingers at 1 m and 3 m, in 3 cases counting fingers at 3 m and 1.0 logMAR, and in 4 cases 1.0-0.3 logMAR. The visual improvements were detected in 13 cases. The mean age of the cases with NION was 39.6±16.1 years. Twenty two cases with ION consisted of 9 females and 13 males. Systemic diseases in cases with ION were: multiple sclerosis (4 cases), acute lenfositic leukaemia (12 cases), methyl alcohol intoxication (2 cases), ethambutol intoxication (1 case), and Hepatitis B vaccination (1 case). In 12 cases visual acuities were less than counting fingers at 1 m, in 2 cases counting fingers at 1 m and 3 m, in 3 cases between counting fingers at 3 m and 1.0 logMAR, and in 5 cases 1.0 logMAR and 0.3 logMAR. The visual improvements were detected in 16 cases. Color vision defects, relative afferent papillary defect, visual field defects and pathological VER findings were detected in all cases with AON. The reversions of these findings were seen in different levels. Conclusion: While ION is generally seen in elderly aged men, NION is generally seen in the middle aged people. The same results were seen in our study. In the literature it was reported that the visual loss was more severe and the visual outcome was better in NION than ION, but in our study, both the visual loss and the visual improvements were better in NION than ION.

Özet

Amaç: Kliniğimizde takibi yapılan ön optik nöropatili (ÖON) olguların demografik ve klinik özelliklerini değerlendirmek Gereç ve Yöntem: Bu çalışmaya 1994-2004 yılları arasında ÖON tanısı konulup takibi yapılan 51 olgunun 51 gözü alındı. Çalışmamızda 29 iskemik optik nöropati (İON) ve 22 iskemik olmayan optik nöropati (İOON)’li olgu vardı. Olguların demografik ve klinik özellikleri saptandı ve bütün olgular sistemik hastalık yönünden dahiliye, romatoloji, nöroloji ve gerekli olan durumlarda hematoloji uzmanlarınca değerlendirildi. Bulgular: İON olguların yaş ortalamaları 62.3±8.5 yıldı. İON’li 29 olgunun 11’i kadın 18’i erkekti. İON’li olgularda sistemik hastalıklar; temporal arterit (2 olgu), hipertansiyon (13 olgu), tip 2 diyabetes mellitus (6 olgu), hipertansiyon + tip 2 diyabetes mellitus (4 olgu), kronik obstrüktif akciğer hastalığı (2 olgu) şeklinde idi. İON grubunda görme düzeyi 15 olguda 1 mps’den az, 7 olguda 1-3 mps, 3 olguda 3 mps-1.0 logMAR, 4 olguda ise 1.0-0.3 logMAR idi. Takiplerde 13 olguda görme düzeyinde artış oldu. İOON’li olguların yaş ortalamaları 39.6±16.1 yıldı. İOON’li 22 olgunun 9’u kadın 13’ü erkekti. İOON’li olgularda sistemik hastalıklar; Multipl Skleroz (4 olgu), akut lenfositer lösemi (2 olgu), metil alkol intoksikasyonu (2 olgu), etambütol intoksikasyonu (1 olgu), Hepatit B aşı öyküsü (1 olgu) şeklinde idi. Görme düzeyi 12 olguda 1 mps’den az, 2 olguda 1-2 mps, 3 olguda 3 mps -1.0 logMAR arası, 5 olguda ise 1.0-0.3 logMAR idi. Takiplerde 16 olguda görme düzeyinde artış görüldü. Tüm olgularda renk görme, ışık reaksiyonu, görme alanı ve VEP bulgularında bozukluklar vardı. Bulgulardaki geriye dönüş farklı düzeylerde görüldü. Sonuç: İON genelde ileri yaşlardaki erkeklerde sık görülürken, İOON orta yaşlarda görülür. Çalışmamızda benzer sonuçlar görüldü. Literatürde İOON’de görme kaybı İON’den daha ağır, görme düzelmesi ise daha iyi olarak rapor edilmiştir. Çalışmamızda ise hem görme kaybı hem de görme düzelmesi İOON’de İON’den daha iyi olarak bulundu.

🔖

Cite This Article

ÖZER, A., SEVİM, S., EROL, N., YURDAKUL, S. (2006). Demographic and clinical characteristics of cases with anterior optic neuropathy. MN Oftalmoloji, Cilt: 13 - Sayı: 3, 211–216. https://ajindex.com/articles/296022

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kansu T. Optik nöropatiler. Ret-Vit 1994; 2:119-24. Aydın P. Görme azlığı-prekiyazmatik lezypnlar. MN Oftalmo­ loji 1995; 2:198-200. Beck RW. Inflammatory Optic Neuropathies and Neuroreti- nitis. In: Yanoff M, Duker JS, editors. Ophthalmology. Barce­ lona; Mosby 1999; 11:1-4. Arnold AC. Ischemic Optic Neuropathies, Diabetic Papillo- pathy, and Papillophlebitis. In: Yanoff M, Duker JS, editors. Ophthalmology. Barcelona; Mosby 1999; 11:1-6.
  2. Subaşı M, Özer A, Or M, Ataoğlu Ö. Temporal arterit. MN Oftalmoloji 1999; 6:40-3.
  3. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. clinical"characteristics and prognosis for vision. Ophthalmology 1994; 101:1779-85.
  4. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994; 118:766-80.
  5. Tezel G, Kansu T, Tezel T. Non-arteritik anterior iskemik optik nöropatide predispozan faktörler. MN Oftalmoloji 1995; 2:82-9.
  6. Jacobson DM, Vierkant RA, Belongia EA. Nonarteritic anterior ischemic optic neuropathy. A case-control study of potential, risk factors. Arch Ophthalmol 1997; 115:1403-7. Salomon 0, Huna-Baron R, Kurtz S, et al. Analysis of prot- hrombotic and vascular risk factors in patients with nonar­ teritic anterior ischemic optic neuropathy. Ophthalmology 1999; 106:739-42. Arnold AC. Evolving management of optic neuritis and multiple sclerosis. Am J Ophthalmol 2005; 139:1101-8.
  7. Chung SM, Gay CA, McCrary JA. Nonarteritic ischemic op­ tic neuropathy, the impact of tobacco use. Ophthalmology 1994; 101:779-82.
  8. Talks SJ, Chong NH, Gibson JM, Dodson PM. Fibririogen, cholesterol and smoking as risk factors for non-arteritic anterior ischaemic optic neuropathy. Eye 1995: 9:85-8.
  9. Johnson LN, Botelho PJ, Kuo HC. Is smoking a risk factor for NAION (nonarteritic anterior ischemic optic neuropathy)? Ophthalmology 1994; 101:1322-4.
  10. Hamurcu MŞ, Kalaycı D, Şengün A. Nonarteritik iskemik optik nöropati ve optik nevrit olgularımızın değerlendirilmesi. MN Oftalmoloji 2001; 8:388-91.
  11. Rizzo JF, Lessell S. Optic neuritis and ischemic optic neuro­ pathy. Arch Ophthalmol 1991; 109:1665-72.
  12. Dunker S, Wiegand W. Prognostic value of magnetic reso­ nance imaging in monosymtomatic optic neuritis. Ophthal­ mology 1996; 103:1768-73.
  13. Beck RW, Hayreh SS, Podhajsky PA, Tan ES, Moke PS. Aspirin therapy in nonarteritic anterior ischemic optic neuro­ pathy. Am J Ophthalmol 1997; 123:212-7.
  14. Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior isc